Granite Investment Partners, LLC Champions Oncology, Inc. Transaction History

Granite Investment Partners, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 10, 2020	SELL	$5.12 - $8.33 $524,805 - $853,833	-102,501 Closed	0 $0
Q2 2019 Aug 07, 2019	SELL	$7.51 - $10.12 $676,095 - $911,063	-90,026 Reduced 46.76%	102,501 $803,000
Q1 2019 May 13, 2019	BUY	$7.89 - $12.23 $710,305 - $1.1 Million	90,026 Added 87.83%	192,527 $1.88 Million
Q4 2018 Feb 13, 2019	SELL	$7.29 - $15.27 $271,166 - $567,998	-37,197 Reduced 26.63%	102,501 $800,000
Q1 2018 May 04, 2018	BUY	$3.39 - $4.39 $473,576 - $613,274	139,698 New	139,698 $509,000

5.82M

15K

Ticker CSBR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 13,522,400
Market Cap $102M
Description
Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company, through its Tumorgraft Techn...

Get notified when there are updates to the investment portfolio of Granite Investment Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Granite Investment Partners, LLC with notifications on news.